Raanana, Israel

Menashe Benjamin

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Algotec Systems Ltd., Philips Medical Systems Technologies Ltd.. Active years: 2005-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Menashe Benjamin. Retrieved from https://idiyas.com/inventor/menashe-benjamin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2005-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Menashe Benjamin: Pioneering Innovations in Raanana, IL

Introduction: Menashe Benjamin is a distinguished inventor based in Raanana, Israel, known for his groundbreaking contributions to various technological fields.

Latest Patents: Menashe Benjamin holds several patents in the areas of renewable energy technologies, artificial intelligence systems, and medical devices, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Menashe Benjamin has worked with leading research institutions and tech companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Menashe Benjamin has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, fostering a culture of creativity and excellence in the industry.

Conclusion: Menashe Benjamin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Raanana, Israel, and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…